Salt Lake City (ots/PRNewswire) - - Clinical studies on point-of-care wrist imaging planned at UCLA - Using this novel compact MRI platform Aspect Imaging, the world leading developer of compact high-performance magnets, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's ...
http://resources.euroadhoc.com/us/ZP1fI8rj issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard: ...
Calgary, Alberta (ots/PRNewswire) - IVUS data will evaluate plaque regression in patients with high-risk Cardiovascular Disease TSX Exchange Symbol: RVX Resverlogix Corp. today announced that it has completed dosing in ASSURE, a Phase 2b clinical trial evaluating RVX-208, Resverlogix's first-in-class orally active BET-protein inhibitor, using intra-vascular ultrasound (IVUS) in high-risk cardiovascular patients with low ...
Amsterdam (ots/PRNewswire) - Record numbers, a focus on development initiatives and analysis of the regional harmonisation programme helps stimulate increased partnerships CPhI, a division of UBM Live, announces that this year's recent CPhI South East Asia 2013, which ran from 20-22nd March at the Jakarta International Expo in Indonesia, was the most successful so far. ...
Ghent, Belgium (ots/PRNewswire) - Two independent validation studies demonstrate that Pronota's biomarker CD146 significantly improves the diagnosis of acute heart failure for patients with shortness of breath. The biomarker, measured in blood, provides clinicians with unique additional information allowing better treatment of this challenging group of patients. ...
The International Osteoporosis Foundation (IOF)
Rome, Italy (ots) - Every year 43,000 people die following osteoporotic fractures; reports show that European healthcare systems are not treating people at risk; burden and costs will rise dramatically by 2025. Two landmark multi-stakeholder reports launched today - Osteoporosis in the European Union and the Scorecard for Osteoporosis in Europe - describe and compare the epidemiology, burden, and management of ...
Paris (ots/PRNewswire) - - Worldwide invitation to create and submit concepts for a potential next-generation insulin delivery device - Sanofi announced today that it is accepting submissions for Ignite: The Diabetes Ideas Challenge ("Ignite Challenge"). The web-based Ignite Challenge invites patients, caregivers, designers, engineers, and innovators from around the ...
Lyon, France (ots/PRNewswire) - - Addition of fourth influenza virus strain aims to increase protection against influenza - Sanofi Pasteur MSD, the joint venture between MSD and Sanofi Pasteur, announced today that it has submitted a decentralized marketing authorization application in Europe for a 'Quadrivalent' influenza vaccine, a new advanced seasonal flu vaccine. ...
Blainville, Canada (ots/PRNewswire) - Following the US approval of its morning sickness medication Diclegis by the US Food and Drug Administration (FDA) [http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm347087.htm ], the Canadian pharmaceutical company Duchesnay Inc. ...
Calgary, Canada (ots/PRNewswire) - Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") today announced that its Board of Directors has approved a proposal to spin-out its subsidiary, RVX Therapeutics Inc. ("RVX Therapeutics"), which will focus on innovative drug research and development by leveraging its epigenetics ...
http://resources.euroadhoc.com/us/YgQnBzd2 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Hatfield, England (ots/PRNewswire) - Child friendly formulation will help treatment of orphan syndrome LGS a severe form of childhood epilepsy Inovelon(R) (rufinamide) oral suspension for adjunctive (add-on) treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children four years and older is launched today in France. The new formulation of the orphan ...
London And Boston (ots/PRNewswire) - EP Vantage(R) [http://www.epvantage.com/default.aspx ], EvaluatePharma(R) [http://www.evaluatepharma.com ]'s award-winning editorial team, today released its "2012 Year in Review [http://www.evaluatepharma.com/epvreview2012 ]" report. Despite numerous ups and downs, the sector exited on a positive note, giving hope that 2013 might be the start of sustained recovery. According to the report, Biotech stocks stormed ahead with the NASDAQ ...
http://resources.euroadhoc.com/us/jG8iMykS issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease Shire plc today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California. This acquisition continues to build Shire's presence in the ...
Takeda Pharmaceuticals Europe Ltd
Zurich, Switzerland (ots/PRNewswire) - Demonstrates Takeda's long-term commitment to the Latin American market Takeda Pharmaceuticals International GmbH ("Takeda"), today announced further expansion of its presence in Latin America with the launch of its wholly-owned subsidiary in Ecuador. Takeda Ecuador S.A. (Takeda Ecuador or "the Company") will be headquartered in Quito and will be responsible for the sales and ...
Ballerup, Denmark (ots/PRNewswire) - Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 months An analysis of long-term clearance rates of actinic keratosis (AK) lesions after treatment with ingenol mebutate (Picato(R)) gel is today published in the Journal of the American ...
European Crop Protection Association
Brussels (ots/PRNewswire) - Today the European Food Safety Authority's (EFSA) Scientific Committee published its opinion on identifying endocrine disrupting chemicals (EDs). ECPA welcomed the EFSA opinion but is concerned how late the input has been requested in a process that has been rushed to meet political ...
Virobay, Inc. and LEO Pharma A/S
Menlo Park, California And Ballerup, Denmark (ots/PRNewswire) - Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development of an oral treatment for psoriasis has reached an important milestone as Virobay has now initiated a Phase 1 clinical trial of VBY-891 - a selective cathepsin S ...
Milan (ots/PRNewswire) - Dr Pieter Groenendijk Wins $150,000 Grant to Support his Research in Understanding Urethral Pressure Variations During Filling Cystometry The Astellas European Foundation is pleased to announce Dr Pieter Groenendijk as the winner of the $150,000 Functional Urology and Uro-Gynaecology Grant. Dr Groenendijk, a urologist from Medisch Centrum ...
European Crop Protection Association
Brussels (ots/PRNewswire) - ECPA recommends proportionate, evidence-based approach, as Standing Committee delivers 'no opinion' on neonicotinoids Member States have failed to reach a qualified majority in a vote potentially leading to a ban on the use of neonicotinoid based pesticides on crops attractive to bees. The European Commission's Appeal Committee will now ...
FC Barcelona and The European Commission
Brussels (ots/PRNewswire) - Today, an important benchmark of more than 60,000 smokers across Europe has been reached with the innovative smoking cessation programme, 'Quit Smoking With Barça' (http://www.quitsmokingwithbarca.eu). This programme is a collaborative effort between FC Barcelona (FCB) and the European Commission. This notable achievement comes less than ...
Astellas Pharma Europe Limited
Chertsey, England (ots/PRNewswire) - - For Healthcare and Business Media - Approval allows for more flexible approach to 8% capsaicin patch treatment of peripheralneuropathic pain The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Deal Enhances Shire's Late-Stage Pipeline with the Acquisition of a Phase II Protein Replacement Therapy Being Investigated for the Prevention of Retinopathy of Prematurity Shire plc announces that it has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein replacement therapy, currently in Phase II development, for the prevention of retinopathy of prematurity (ROP). ROP is a rare ...
SIU-Societe Internationale d'Urologie
Montreal (ots/PRNewswire) - The Société Internationale d'Urologie is pleased to announce the launch of SIU Academy [http://www.siu-academy.org ], a powerful new eLearning resource for urologists. Engineered for the cloud, SIU Academy [http://www.siu-academy.org ] can be accessed anywhere in the world. All users ...
Frankfurt, Germany And Hatfield, England (ots/PRNewswire) - The German Federal Joint Committee (G-BA), the decision-making body of the self-governing medical system in Germany, today announced that it considers the additional benefit of Fycompa(R) (perampanel) unproven when compared to two other treatments as ...
Aarhus, Denmark (ots/PRNewswire) - Danish medtech company Unisense FertiliTech A/S announces a new partnership with the Danish Pension Fund PKA. PKA owns 25% of Unisense FertiliTech A/S after the purchase of shares in the company worth 20 million USD. This brings the total of new investment in the company over the past 3 months to 45 million USD. Unisense FertiliTech ...
Hitachi Medical Systems Europe Holding AG
Sunnyvale, California (ots/PRNewswire) - Accuray Incorporated [http://www.accuray.com ] , today announced highlights from the First European Conference on stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) and image-guided intensity-modulated radiation therapy (IG-IMRT), hosted in partnership with the Istituto Europeo di Oncologia Milano and the Universita degli studi di Milano, held in Milan, Italy ...
Maidenhead, England (ots/PRNewswire) - --Rare Disease Day takes place on 28 February 2013 and this year's theme focuses on 'Rare Disorders without Borders'-- --ViroPharma Incorporated is an international biopharmaceutical company committed to supporting patients with serious diseases for which there is an unmet medical need-- ViroPharma Incorporated , an international biopharmaceutical company committed to supporting ...